Lotus Pharmaceuticals Inc. (OTCMKTS:LTUS) Short Interest Update

Lotus Pharmaceuticals Inc. (OTCMKTS:LTUS) was the target of a large drop in short interest during the month of May. As of May 29th, there was short interest totaling 7,566 shares, a drop of 56.9% from the May 14th total of 17,566 shares. Based on an average trading volume of 10,000 shares, the days-to-cover ratio is presently 0.8 days. Currently, 0.0% of the company’s shares are sold short.

Lotus Pharmaceuticals Stock Performance

Shares of LTUS stock opened at $0.00 on Friday. Lotus Pharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week high of $0.01.

Lotus Pharmaceuticals Company Profile

Lotus Pharmaceuticals, trading under the symbol LTUS on the OTC Market, is a Taiwan-based pharmaceutical company specializing in the research, development, manufacturing and marketing of prescription medications. The company’s core operations encompass both the production of a broad range of generic drugs and the advancement of novel compounds aimed at therapeutic areas such as oncology, central nervous system disorders, cardiovascular diseases and anti-infective treatments.

Lotus Pharmaceuticals offers multiple dosage forms, including tablets, capsules, injectables and sterile preparations, to meet the needs of hospital and retail pharmacy channels.